Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration

Redox Biology

Volumn 7, Issue , 2016, Pages 78-87

  Marazita, Mariela C ^a   Dugour, Andrea ^b   Marquioni Ramella, Melisa D ^a   Figueroa, Juan M ^b   Suburo, Angela M ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b Fundacion Pablo Cassara   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; BETA GALACTOSIDASE; CIGARETTE SMOKE; COMPLEMENT FACTOR H; HISTONE H2AX; HYDROGEN PEROXIDE; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P16; PROTEIN P21; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; COMPLEMENT FACTOR H, HUMAN; INTERLEUKIN DERIVATIVE; SMOKE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; ARPE 19 CELL LINE; ARTICLE; CELL AGING; CELL CULTURE; CELL LINE; CELL VIABILITY; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; OXIDATIVE STRESS INDUCED PREMATURE SENESCENCE; PHOTOOXIDATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINA; UPREGULATION; ADVERSE EFFECTS; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACULAR DEGENERATION; METABOLISM; PATHOLOGY; RETINAL PIGMENT EPITHELIUM; SMOKE; TOBACCO;

CELL AGING; CELL LINE; CELL SURVIVAL; COMPLEMENT FACTOR H; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; INTERLEUKINS; MACULAR DEGENERATION; OXIDATIVE STRESS; RETINAL PIGMENT EPITHELIUM; SMOKE; TOBACCO; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84949294022     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.11.011     Document Type: Article

References (93)

1. Owen C.G., Jarrar Z., Wormald R., Cook D.G., Fletcher A.E., Rudnicka A.R. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br. J. Ophthalmol. 2012, 96(5):752-756. 10.1136/bjophthalmol-2011-301109.
2. Lim L.S., Mitchell P., Seddon J.M., Holz F.G., Wong T.Y. Age-related macular degeneration. Lancet 2012, 379(9827):1728-1738. 10.1016/S0140-6736(12)60282-7.
3. Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis The Lancet. Glob. Health 2014, 2(2):e106-e116. 10.1016/S2214-109X(13)70145-1.
4. Ach T., Huisingh C., McGwin G., Messinger J.D., Zhang T., Bentley M.J., Gutierrez D.B., Ablonczy Z., Smith R.T., Sloan K.R., Curcio C.A. Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 2014, 55(8):4832-4841. 10.1167/iovs.14-14802.
5. Ach T., Tolstik E., Messinger J.D., Zarubina A.V., Heintzmann R., Curcio C.A. Lipofuscin redistribution and loss accompanied by cytoskeletal stress in retinal pigment epithelium of eyes with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2015, 56(5):3242-3252. 10.1167/iovs.14-16274.
6. Kent D.L. Age-related macular degeneration: beyond anti-angiogenesis. Mol. Vis. 2014, 20:46-55.
7. Cousins S.W., Espinosa-Heidmann D.G., Alexandridou A., Sall J., Dubovy S., Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp. Eye Res. 2002, 75(5):543-553.
8. Marin-Castaño M.E., Striker G.E., Alcazar O., Catanuto P., Espinosa-Heidmann D.G., Cousins S.W. Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Investig. Ophthalmol. Vis. Sci. 2006, 47(9):4098-4112. 10.1167/iovs.05-1230.
9. Suzuki M., Tsujikawa M., Itabe H., Du Z.J., Xie P., Matsumura N., Fu X., Zhang R., Sonoda K.H., Egashira K., Hazen S.L., Kamei M. Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J. Cell. Sci. 2012, 125(Pt 10):2407-2415. 10.1242/jcs.097683.
10. Jarrett S.G., Boulton M.E. Consequences of oxidative stress in age-related macular degeneration. Mol. Asp. Med. 2012, 33(4):399-417. 10.1016/j.mam.2012.03.009.
11. Cano M., Thimmalappula R., Fujihara M., Nagai N., Sporn M., Wang A.L., Neufeld A.H., Biswal S., Handa J.T. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and age-related macular degeneration. Vis. Res. 2010, 50(7):652-664. 10.1016/j.visres.2009.08.018.
12. Winkler B.S., Boulton M.E., Gottsch J.D., Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 1999, 5:32.
13. Cadet J., Douki T., Ravanat J.L. Oxidatively generated base damage to cellular DNA. Free Radic. Biol. Med. 2010, 49(1):9-21. 10.1016/j.freeradbiomed.2010.03.025.
14. Campisi J., Robert L. Cell senescence: role in aging and age-related diseases Interdisciplinary topics in. Gerontology 2014, 39:45-61. 10.1159/000358899.
15. Matsunaga H., Handa J.T., Aotaki-Keen A., Sherwood S.W., West M.D., Hjelmeland L.M. Beta-galactosidase histochemistry and telomere loss in senescent retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 1999, 40(1):197-202.
16. Kozlowski M.R. RPE cell senescence: a key contributor to age-related macular degeneration. Med. Hypotheses 2012, 78(4):505-510. 10.1016/j.mehy.2012.01.018.
17. Honda S., Hjelmeland L.M., Handa J.T. Senescence associated beta galactosidase activity in human retinal pigment epithelial cells exposed to mild hyperoxia in vitro. Br. J. Ophthalmol. 2002, 86(2):159-162.
18. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell. Biol. 2011, 192(4):547-556. 10.1083/jcb.201009094.
19. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2010, 24(22):2463-2479. 10.1101/gad.1971610.
20. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
21. Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J.L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Investig. 2013, 123(3):966-972. 10.1172/JCI64098.
22. Ambati J., Atkinson J.P., Gelfand B.D. Immunology of age-related macular degeneration. Nat. Rev. Immunol. 2013, 13(6):438-451. 10.1038/nri3459.
23. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308(5720):421-424. 10.1126/science.1110189.
24. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G., Hauser M.A., Rickman C.B., Bok D., Hageman G.S., Johnson L.V. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 2010, 29(2):95-112. 10.1016/j.preteyeres.2009.11.003.
25. Bora N.S., Matta B., Lyzogubov V.V., Bora P.S. Relationship between the complement system, risk factors and prediction models in age-related macular degeneration. Mol. Immunol. 2015, 63(2):176-183. 10.1016/j.molimm.2014.07.012.
26. Miller J.W., Le Couter J., Strauss E.C., Ferrara N. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 2013, 120(1):106-114. 10.1016/j.ophtha.2012.07.038.
27. Seddon J.M., George S., Rosner B., Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 2005, 123(6):774-782. 10.1001/archopht.123.6.774.
28. Goverdhan S.V., Ennis S., Hannan S.R., Madhusudhana K.C., Cree A.J., Luff A.J., Lotery A.J. Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration. Br. J. Ophthalmol. 2008, 92(4):537-540. 10.1136/bjo.2007.123190.
29. Tsai Y.Y., Lin J.M., Wan L., Lin H.J., Tsai Y., Lee C.C., Tsai C.H., Tsai F.J., Tseng S.H. Interleukin gene polymorphisms in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2008, 49(2):693-698. 10.1167/iovs.07-0125.
30. Lechanteur Y.T., van de Camp P.L., Smailhodzic D., van de Ven J.P., Buitendijk G.H., Klaver C.C., Groenewoud J.M., den Hollander A.I., Hoyng C.B., Klevering B.J. Association of smoking and CFH and ARMS2 risk variants with younger age at onset of neovascular age-related macular degeneration. JAMA Ophthalmol. 2015, 133(5):533-541. 10.1001/jamaophthalmol.2015.18.
31. Thornton J., Edwards R., Mitchell P., Harrison R.A., Buchan I., Kelly S.P. Smoking and age-related macular degeneration: a review of association. Eye 2005, 19(9):935-944. 10.1038/sj.eye.6701978.
32. Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Yates J.R., Bradley M., Moore A.T., Bird A.C. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br. J. Ophthalmol. 2006, 90(1):75-80. 10.1136/bjo.2005.073643.
33. Chakravarthy U., Wong T.Y., Fletcher A., Piault E., Evans C., Zlateva G., Buggage R., Pleil A., Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010, 10:31. 10.1186/1471-2415-10-31.
34. Mitchell P., Wang J.J., Smith W., Leeder S.R. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol. 2002, 120(10):1357-1363.
35. Choudhury F., Varma R., McKean-Cowdin R., Klein R., Azen S.P., Los Angeles Latino Eye Study G. Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study. Am. J. Ophthalmol. 2011, 152(3):385-395. 10.1016/j.ajo.2011.02.025.
36. Kabasawa S., Mori K., Horie-Inoue K., Gehlbach P.L., Inoue S., Awata T., Katayama S., Yoneya S. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 2011, 118(6):1082-1088. 10.1016/j.ophtha.2010.10.012.
37. Woodell A., Rohrer B. A mechanistic review of cigarette smoke and age-related macular degeneration. Adv. Exp. Med. Biol. 2014, 801:301-307. 10.1007/978-1-4614-3209-8_38.
38. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45(2):115-134.
39. Cai J., Nelson K.C., Wu M., Sternberg P., Jones D.P. Oxidative damage and protection of the. RPE Prog. Retin. Eye Res. 2000, 19(2):205-221.
40. Wang Z., Wei D., Xiao H. Methods of cellular senescence induction using oxidative stress. Methods Mol. Biol. 2013, 1048:135-144. 10.1007/978-1-62703-556-9_11.
41. S. Kasibhatla, G.P. Amarante-Mendes, D. Finucane, T. Brunner, E. Bossy-Wetzel, and D.R. Green, Acridine Orange/Ethidium Bromide (AO/EB) Staining to Detect Apoptosis Cold Spring Harb Protoc 2006 (3), http://dx.doi.org/10.1101/pdb.prot4493.
42. Lee S.F., Pervaiz S. Assessment of oxidative stress-induced DNA damage by immunoflourescent analysis of 8-oxodG. Methods Cell. Biol. 2011, 103:99-113. 10.1016/B978-0-12-385493-3.00005-X.
43. Debacq-Chainiaux F., Erusalimsky J.D., Campisi J., Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 2009, 4(12):1798-1806. 10.1038/nprot.2009.191.
44. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells Nature reviews. Mol. Cell. Biol. 2007, 8(9):729-740. 10.1038/nrm2233.
45. Coppe J.P., Rodier F., Patil C.K., Freund A., Desprez P.Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 2011, 286(42):36396-36403. 10.1074/jbc.M111.257071.
46. Siemerink M.J., Augustin A.J., Schlingemann R.O. Mechanisms of ocular angiogenesis and its molecular mediators. Dev. Ophthalmol. 2010, 46:4-20. 10.1159/000320006.
47. Sene A., Chin-Yee D., Apte R.S. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol. Med. 2015, 21(1):43-51. 10.1016/j.molmed.2014.10.005.
48. Chen M., Forrester J.V., Xu H. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp. Eye Res. 2007, 84(4):635-645. 10.1016/j.exer.2006.11.015.
49. Naylor R.M., Baker D.J., van Deursen J.M. Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin. Pharmacol. Ther. 2013, 93(1):105-116. 10.1038/clpt.2012.193.
50. Neuner B., Komm A., Wellmann J., Dietzel M., Pauleikhoff D., Walter J., Busch M., Hense H.W. Smoking history and the incidence of age-related macular degeneration--results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict. Behav. 2009, 34(11):938-947. 10.1016/j.addbeh.2009.05.015.
51. Lamb T.D., Pugh E.N. Phototransduction, dark adaptation, and rhodopsin regeneration the proctor lecture. Investig. Ophthalmol. Vis. Sci. 2006, 47(12):5137-5152. 10.1167/iovs.06-0849.
52. Marquioni-Ramella M.D., Suburo A.M. Photo-damage, photo-protection and age-related macular degeneration. Photochem. Photobiol. Sci. 2015, 14:1560-1577. 10.1039/c5pp00188a.
53. Jones D.P. Redox theory of aging. Redox Biol. 2015, 5:71-79. 10.1016/j.redox.2015.03.004.
54. Yamashita H., Horie K., Yamamoto T., Nagano T., Hirano T. Light-induced retinal damage in mice. Hydrogen peroxide production and superoxide dismutase activity in retina. Retina 1992, 12(1):59-66.
55. Pryor W.A., Church D.F., Evans M.D., Rice W.Y., Hayes J.R. A comparison of the free radical chemistry of tobacco-burning cigarettes and cigarettes that only heat tobacco. Free Radic. Biol. Med. 1990, 8(3):275-279.
56. Lykkesfeldt J., Christen S., Wallock L.M., Chang H.H., Jacob R.A., Ames B.N. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am. J. Clin. Nutr. 2000, 71(2):530-536.
57. Jubri Z., Latif A.A., Top A.G., Ngah W.Z. Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation. Nutr. J. 2013, 12:2. 10.1186/1475-2891-12-2.
58. Yu A.L., Birke K., Burger J., Welge-Lussen U. Biological effects of cigarette smoke in cultured human retinal pigment epithelial cells. PloS One 2012, 7(11):e48501. 10.1371/journal.pone.0048501.
59. Yu A.L., Fuchshofer R., Kook D., Kampik A., Bloemendal H., Welge-Lussen U. Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Investig. Ophthalmol. Vis. Sci. 2009, 50(2):926-935. 10.1167/iovs.07-1003.
60. Nakamura A.J., Chiang Y.J., Hathcock K.S., Horikawa I., Sedelnikova O.A., Hodes R.J., Bonner W.M. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenet. Chromatin 2008, 1(1):6.
61. Mishima K., Handa J.T., Aotaki-Keen A., Lutty G.A., Morse L.S., Hjelmeland L.M. Senescence-associated beta-galactosidase histochemistry for the primate eye. Investig. Ophthalmol. Vis. Sci. 1999, 40(7):1590-1593.
62. Zhu D., Wu J., Spee C., Ryan S.J., Hinton D.R. BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J. Biol. Chem. 2009, 284(14):9529-9539. 10.1074/jbc.M809393200.
63. Liu C., Cao L., Yang S., Xu L., Liu P., Wang F., Xu D. Subretinal injection of amyloid-beta peptide accelerates RPE cell senescence and retinal degeneration. Int. J. Mol. Med. 2015, 35(1):169-176. 10.3892/ijmm.2014.1993.
64. Fossel M. Cell senescence in human aging and disease. Ann. N. Y. Acad. Sci. 2002, 959:14-23.
65. Patil C.K., Mian I.S., Campisi J. The thorny path linking cellular senescence to organismal aging. Mech. Ageing Dev. 2005, 126(10):1040-1045. 10.1016/j.mad.2005.08.001.
66. Chinta S.J., Woods G., Rane A., Demaria M., Campisi J., Andersen J.K. Cellular senescence and the aging brain. Exp. Gerontol. 2015, 68:3-7. 10.1016/j.exger.2014.09.018.
67. Bhayadia R., Schmidt B.M., Melk A., Homme M. Senescence-induced oxidative stress causes endothelial dysfunction. Journals of Gerontology: Biological SCIENCES 2015, 68:1-9. 10.1093/gerona/glv008.
68. Aoshiba K., Zhou F., Tsuji T., Nagai A. DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur. Respir. J. 2012, 39(6):1368-1376. 10.1183/09031936.00050211.
69. Liu J., Yang J.R., Chen X.M., Cai G.Y., Lin L.R., He Y.N. Impact of ER stress-regulated ATF4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. Am. J. Physiol. Cell. Physiol. 2015, 308(8):C621-C630. 10.1152/ajpcell.00096.2014.
70. Zhou H.W., Lou S.Q., Zhang K. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology 2004, 43(5):555-568. 10.1093/rheumatology/keh127.
71. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479(7372):232-236. 10.1038/nature10600.
72. Velarde M.C., Demaria M., Campisi J. Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip. Topics Gerontol. 2013, 38:17-27. 10.1159/000343572.
73. Ovadya Y., Krizhanovsky V. Senescent cells: SASPected drivers of age-related pathologies. Biogerontology 2014, 15(6):627-642. 10.1007/s10522-014-9529-9.
74. Cao L., Wang H., Wang F., Xu D., Liu F., Liu C. Abeta-induced senescent retinal pigment epithelial cells create a proinflammatory microenvironment in AMD. Investig. Ophthalmol. Vis. Sci. 2013, 54(5):3738-3750. 10.1167/iovs.13-11612.
75. Jonas J.B., Tao Y., Neumaier M., Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. 2012, 90(5):e381-e388. 10.1111/j.1755-3768.2012.02414.x.
76. Roh M.I., Kim H.S., Song J.H., Lim J.B., Koh H.J., Kwon O.W. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 2009, 29(4):523-529. 10.1097/IAE.0b013e318195cb15.
77. Miao H., Tao Y., Li X.X. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol. Vis. 2012, 18:574-580.
78. Leung K.W., Barnstable C.J., Tombran-Tink J. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol. Immunol. 2009, 46(7):1374-1386. 10.1016/j.molimm.2008.12.001.
79. Solomon S.D., Lindsley K., Vedula S.S., Krzystolik M.G., Hawkins B.S. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst. Rev. 2014, 8:CD005139. 10.1002/14651858.CD005139.pub3.
80. Ablonczy Z., Dahrouj M., Marneros A.G. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels. FASEB J. 2014, 28(5):2369-2379. 10.1096/fj.13-248021.
81. Coppe J.P., Kauser K., Campisi J., Beausejour C.M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 2006, 281(40):29568-29574. 10.1074/jbc.M603307200.
82. Glotin A.L., Debacq-Chainiaux F., Brossas J.Y., Faussat A.M., Treton J., Zubielewicz A., Toussaint O., Mascarelli F. Prematurely senescent ARPE-19 cells display features of age-related macular degeneration. Free Radic. Biol. Med. 2008, 44(7):1348-1361. 10.1016/j.freeradbiomed.2007.12.023.
83. Succoio M., Comegna M., D'Ambrosio C., Scaloni A., Cimino F., Faraonio R. Proteomic analysis reveals novel common genes modulated in both replicative and stress-induced senescence. J. Proteom. 2015, 128:18-29. 10.1016/j.jprot.2015.07.010.
84. Lyzogubov V.V., Tytarenko R.G., Jha P., Liu J., Bora N.S., Bora P.S. Role of ocular complement factor H in a murine model of choroidal neovascularization. Am. J. Pathol. 2010, 177(4):1870-1880. 10.2353/ajpath.2010.091168.
85. Bhutto I.A., Baba T., Merges C., Juriasinghani V., McLeod D.S., Lutty G.A. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br. J. Ophthalmol. 2011, 95(9):1323-1330. 10.1136/bjo.2010.199216.
86. Bischof O., Martinez-Zamudio R.I. MicroRNAs and lncRNAs in senescence: a re-view. IUBMB Life 2015, 67(4):255-267. 10.1002/iub.1373.
87. Abdelmohsen K., Gorospe M. Noncoding RNA control of cellular senescence. Wiley Interdiscip. Rev. RNA 2015, 6(6):615-629. 10.1002/wrna.1297.
88. Serrano M. The inflammtory powers of senescence. Trends Cell Biol. 2015, 25(11):634-636. 10.1016/j.tcb.2015.09.011.
89. Lukiw W.J., Surjyadipta B., Dua P., Alexandrov P.N. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int. J. Biochem. Mol. Biol. 2012, 3(1):105-116.
90. O'Loghlen A., Brookes S., Martin N., Rapisarda V., Peters G., Gil J. CBX7 and miR-9 are part of an autoregulatory loop controlling p16. Aging Cell 2015, 14(6):1113-1121.
91. Rippe C., Blimline M., Magerko K.A., Lawson B.R., LaRocca T.J., Donato A.J., Seals D.R. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp. Gerontol. 2012, 47(1):45-51. 10.1016/j.exger.2011.10.004.
92. Rippo M.R., Olivieri F., Monsurro V., Prattichizzo F., Albertini M.C., Procopio A.D. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a. Exp. Gerontol. 2014, 56:154-163. 10.1016/j.exger.2014.03.002.
93. Olivieri F., Albertini M.C., Orciani M., Ceka A., Cricca M., Procopio A.D., Bonafe M. DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging. Oncotarget 2015, 6(34):35509-35521. 10.18632/oncotarget.5899.